A platform has been developed to track the mutational impact of SARS-CoV-2 on disease severity and identify effective therapeutic inhibitors.
A platform has been developed to track the mutational impact of SARS-CoV-2 on disease severity and identify effective therapeutic inhibitors. The platform aims to provide valuable insights into the virus's behavior and aid in the development of targeted treatments.
Platform SARS-Cov-2 Mutational Impact Disease Severity Therapeutic Inhibitors
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers predict real-world SARS-CoV-2 evolution by monitoring mutations of viral isolatesJunior Associate Professor Kazuo Takayama (Department of Cell Growth and Differentiation) and a collaborative team of researchers in Japan recently characterized SARS-CoV-2 collected from a persistent COVID-19 patient to identify critical factors responsible for generating new mutant strains.
Read more »
Novel SARS-CoV-2 mutations found in floodwaters near homeless communitiesStudy highlights the detection of SARS-CoV-2 RNA and novel spike gene mutations in flood control channels affected by homeless populations, demonstrating the value of environmental surveillance in understanding public health dynamics.
Read more »
Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patientsStudy found that the antiviral molnupiravir affects the evolution of SARS-CoV-2 in immunocompromised patients, suggesting its use modifies viral mutation patterns and may impact viral evolution.
Read more »
Vaccine monitoring is crucial as SARS-CoV-2 variants continue to evolve, says studyResearchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.
Read more »
Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccinesResearchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.
Read more »
Mutations do not predict the severity of current variants of SARS-CoV-2, finds studyNew research from UNC Charlotte's Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.
Read more »